Carbapenemase-producing bacteria in companion animals: a public health concern on the horizon
Open Access
- 6 January 2014
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 69 (5), 1155-1157
- https://doi.org/10.1093/jac/dkt518
Abstract
Clinical infections attributed to carbapenemase-producing bacteria are a pressing public health concern owing to limited therapeutic options and linked antimicrobial resistance. In recent years, studies have reported the emergence and spread of carbapenemase-producing Enterobacteriaceae and their public health impact. This has been closely followed by the global dissemination of highly resistant and virulent zooanthroponotic extraintestinal pathogenic Escherichia coli (ExPEC) ST131 clones. It has also been hypothesized that companion animals may act as a reservoir for Gram-negative multidrug-resistant pathogens in the community. Two recent reports have documented the emergence of carbapenemase-producing bacteria in companion animals. This phenomenon is of great concern because of the close contact between humans and their pets, and the potential for cross-species transmission. This scenario suggests a role for multifaceted control of Gram-negative multidrug-resistant infections in companion animals. This short article addresses this issue and identifies steps that could facilitate this process.Keywords
This publication has 25 references indexed in Scilit:
- Carbapenemase-producing Enterobacteriaceae and non-Enterobacteriaceae from animals and the environment: an emerging public health risk of our own making?Journal of Antimicrobial Chemotherapy, 2013
- Emergence of OXA-48 carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in dogsJournal of Antimicrobial Chemotherapy, 2013
- NDM-1 carbapenemase-producing Salmonella enterica subsp. enterica serovar Corvallis isolated from a wild bird in GermanyJournal of Antimicrobial Chemotherapy, 2013
- Emergence of a New Delhi Metallo-β-Lactamase (NDM-1)-Encoding Gene in Clinical Escherichia coli Isolates Recovered from Companion Animals in the United StatesAntimicrobial Agents and Chemotherapy, 2013
- Complete sequence of the blaNDM-1-carrying plasmid pNDM-AB from Acinetobacter baumannii of food animal originJournal of Antimicrobial Chemotherapy, 2013
- Salmonella enterica subsp. enterica producing VIM-1 carbapenemase isolated from livestock farmsJournal of Antimicrobial Chemotherapy, 2012
- Identification of New Delhi Metallo-β-lactamase 1 in Acinetobacter lwoffii of Food Animal OriginPLOS ONE, 2012
- Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence studyThe Lancet Infectious Diseases, 2011
- Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological studyThe Lancet Infectious Diseases, 2010
- Clinically significant carbapenemases: an updateCurrent Opinion in Infectious Diseases, 2008